LIXAZINONE SULFATE ANHYDROUS
UNII OW125J77XM

Substance Identification & Data

This profile provides standardized clinical and technical data for Lixazinone Sulfate Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) OW125J77XM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 108609-34-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
OW125J77XM
CAS Registry Number
108609-34-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LIXAZINONE SULFATE ANHYDROUS
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C21H28N4O3.H2O4S
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
QWZIAYHPUVIQMT-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
N12C(Nc3ccc(cc3C1)OCCCC(=O)N(C4CCCCC4)C)=NC(=O)C2.S(O)(O)(=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lixazinone Sulfate Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

LIXAZINONE SULFATE ANHYDROUS

Systematic Nomenclature

BUTANAMIDE, N-CYCLOHEXYL-N-METHYL-4-((1,2,3,5-TETRAHYDRO-2-OXOIMIDAZO(2,1-B)QUINAZOLIN-7-YL)OXY)-, SULFATE (1:1)